You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Solifenacin Succinate

Showing 1 - 25 of 277
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Overactive Bladder Trial in Shanghai (electroacupuncture, Solifenacin Succinate Tablets)

Not yet recruiting
  • Overactive Bladder
  • electroacupuncture
  • Solifenacin Succinate Tablets
  • Shanghai, Shanghai, China
    Longhua Hospital Shanghai University of Traditional Chinese Medi
Mar 23, 2023

Healthy Trial in Cairo (Vesicare (Solifenacin Succinate 5 mg) & Betmiga (Mirabegron 50 mg) (Reference first dose), Mirfenacin MR

Completed
  • Healthy
  • Vesicare (Solifenacin Succinate 5 mg) & Betmiga (Mirabegron 50 mg) (Reference first dose)
  • +2 more
  • Cairo, Egypt
    Genuine Research Center GRC
Mar 2, 2023

Overactive Bladder, Benign Prostate Hyperplasia, Transurethral Resection of Prostate Trial in Soul (Solifenacin Succinate,

Completed
  • Overactive Bladder
  • +3 more
  • Solifenacin Succinate
  • Placebo
  • Soul, Korea, Republic of
    (unnamed)
Jul 26, 2022

Overactive Bladder in Parkinson's Disease Trial in Miami, Tampa, Atlanta (solifenacin succinate (VESIcare), )

Completed
Has Results
  • Overactive Bladder in Parkinson's Disease
  • solifenacin succinate (VESIcare)
  • placebo
  • Miami, Florida
  • +2 more
Nov 8, 2021

Overactive Bladder Trial in Chongqing (Solifenacin Succinate 5 MG Oral Tablet [Vesicare], Vitamin D3, Standard urotherapy)

Recruiting
  • Overactive Bladder
  • Solifenacin Succinate 5 MG Oral Tablet [Vesicare]
  • +2 more
  • Chongqing, Chongqing, China
    Children's Hospital of Chongqing Medical University
Feb 1, 2023

Ureteral Stent, Stent Related Symptoms Trial in Mansoura (Mirabegron 50 MG, Tamsulosin, Solifenacin Succinate 10 MG)

Recruiting
  • Ureteral Stent
  • Stent Related Symptoms
  • Mirabegron 50 MG
  • +3 more
  • Mansoura, DK, Egypt
    Urology and Nephrology Center
Nov 20, 2021

Overactive Bladder Trial in Seoul (DA-8010 Placebo, DA-8010 2.5mg, DA-8010 5mg)

Recruiting
  • Overactive Bladder
  • DA-8010 Placebo
  • +4 more
  • Seoul, Korea, Republic of
    Severance Hospital
Jun 2, 2022

Overactive Bladder Trial in New Taipei City (Solifenacin Succinate 5mg/tab daily, biofeedback-assisted pelvic floor muscle

Completed
  • Overactive Bladder
  • Solifenacin Succinate 5mg/tab daily
  • biofeedback-assisted pelvic floor muscle training
  • New Taipei City, Taiwan
    Far Eastern Memorial Hospital
Jan 26, 2022

Overactive Bladder Syndrome, Detrusor Overactivity Trial (Mirabegron 50 MG, Solifenacin Succinate 5 MG)

Not yet recruiting
  • Overactive Bladder Syndrome
  • Detrusor Overactivity
  • Mirabegron 50 MG
  • Solifenacin Succinate 5 MG
  • (no location specified)
Jan 25, 2021

Overactive Bladder Trial in Japan (ONO-8577, solifenacin succinate + mirabegron, Placebo)

Completed
  • Overactive Bladder
  • Maebashi, Gunma, Japan
  • +29 more
Oct 21, 2020

Urinary Bladder, Overactive, Urodynamics, Effect of Drug Trial in Taipei (Intradetrusor Botox® (onabotulinumtoxinA) injection,

Recruiting
  • Urinary Bladder, Overactive
  • +2 more
  • Intradetrusor Botox® (onabotulinumtoxinA) injection
  • Combine Mirabegron and Solifenacin.
  • Taipei, Taiwan
    Mackay Memorial Hospital
Jul 29, 2023

Voiding Disorders Trial in Mansoura (Mirabegron, Propevirine, Solifenacin)

Recruiting
  • Voiding Disorders
  • Mirabegron, Propevirine, Solifenacin
  • Mansoura, Egypt
    Urology and Nephrology Center, Mansoura University
Aug 3, 2022

Overactive Bladder Trial in Seoul (DA-8010 Placebo, DA-8010 2.5mg, DA-8010 5mg)

Completed
  • Overactive Bladder
  • DA-8010 Placebo
  • +4 more
  • Seoul, Korea, Republic of
    Severance Hospital
Feb 6, 2020

Overactive Bladder, Overactive Bladder Syndrome Trial in Izmir (Oral Solifenacin 5mg, Transcutaneous Posterior Tibial Nerve

Completed
  • Overactive Bladder
  • Overactive Bladder Syndrome
  • Oral Solifenacin 5mg
  • Transcutaneous Posterior Tibial Nerve Stimulation (TTNS)
  • İzmir, Turkey
    Ege University, School of Medicine, Department of Obstetrics and
Sep 4, 2023

Benign Prostatic Hyperplasia, Overactive Bladder Trial in Mansoura (Tadalafil 5mg, Tamsulosin Hcl 0.4 mg, solifenacin 10 mg)

Active, not recruiting
  • Benign Prostatic Hyperplasia
  • Overactive Bladder
  • Tadalafil 5mg
  • +2 more
  • Mansoura, Egypt
    Urology and Nephrology center
Aug 9, 2022

Solifenacin or Mirabegron in Overactive Bladder Syndrome

Recruiting
  • Overactive Bladder Syndrome
  • Solifenacin Oral Tablet
  • Mirabegron 25mg
  • Banqiao, New Taipei, Taiwan
    Department of Obstetrics and Gynecology, Far-Eastern Memorial Ho
Mar 9, 2022

Hot Flashes, Breast Cancer Trial in Little Rock (solifenacin, Clonidine)

Active, not recruiting
  • Hot Flashes
  • Breast Cancer
  • Little Rock, Arkansas
    Winthrop P. Rockefeller Cancer Institute, University of Arkansas
Jun 8, 2022

Overactive Bladder Syndrome Trial in Banqiao (Mirabegron, Solifenacin)

Recruiting
  • Overactive Bladder Syndrome
  • Banqiao, New Taipei, Taiwan
    Department of Obstetrics and Gynecology, Far-Eastern Memorial Ho
Feb 7, 2022

BOTOX, Percutaneous Tibial Nerve Stimulation Trial in Benha (drug, procedure, combination product)

Not yet recruiting
  • BOTOX
  • Percutaneous Tibial Nerve Stimulation
  • Solifenacin group
  • +3 more
  • Benha, Qalyubiyya, Egypt
    Pediatric Urology departments Benha University Hospitals
Jun 17, 2023

Voiding Disorders Trial in Bani Suwayf (Solifenacin Succinate 5 MG)

Completed
  • Voiding Disorders
  • Solifenacin Succinate 5 MG
  • Banī Suwayf, Beni-Suef, Egypt
    Beni-Suef University
Aug 20, 2019

Voiding Disorders, Overactive Bladder Trial (Beta3-Agonists, Adrenergic, Anticholinergic drug, Solifenacin)

Not yet recruiting
  • Voiding Disorders
  • Overactive Bladder
  • Beta3-Agonists, Adrenergic
  • Anticholinergic drug, Solifenacin
  • (no location specified)
Feb 13, 2022

Overactive Bladder, Urinary Incontinence, Urge, Urgency-frequency Syndrome Trial in Mansoura (Li-SWT (suprapubic approach),

Active, not recruiting
  • Overactive Bladder
  • +3 more
  • Li-SWT (suprapubic approach)
  • +4 more
  • Mansoura, Egypt
    Urology and Nephrology center
Jan 28, 2022

Mixed Urinary Incontinence, Urgency-predominant Mixed Urinary Incontinence Trial in Beijing (electroacupuncture, sham

Recruiting
  • Mixed Urinary Incontinence
  • Urgency-predominant Mixed Urinary Incontinence
  • electroacupuncture
  • +2 more
  • Beijing, China
    Guang An Men Hospital
Feb 2, 2022

Urologic Diseases, Urinary Bladder Diseases, Urological Manifestations Trial in Worldwide (Mirabegron, Solifenacin succinate,

Completed
Has Results
  • Urologic Diseases
  • +4 more
  • Minsk, Belarus
  • +132 more
Dec 17, 2019

Overactive Bladder, Parkinson Disease Trial in United States (solifenacin, Pelvic floor muscle exercise-based behavioral

Recruiting
  • Overactive Bladder
  • Parkinson Disease
  • solifenacin
  • Pelvic floor muscle exercise-based behavioral therapy
  • Birmingham, Alabama
  • +3 more
Jan 7, 2022